Polaryx Therapeutics, Inc. Operating Income increased by 61.2% to -$1.96M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Growth in operating income suggests that the core business is becoming more profitable and efficient.
The profit realized from a business's own operations after deducting operating expenses like wages, depreciation, and co...
This is a key metric for comparing the fundamental business performance of companies with different tax or debt structures.
operating_income| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | -$5.05M | -$1.96M |
| QoQ Change | — | +61.2% |
| YoY Change | — | +61.2% |